Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) has a half-life of approximately five days, meaning it takes roughly four to five weeks for the medicine to clear your system entirely after you stop taking it. That extended duration is why a once-weekly injection sustains its effects between doses — and why effects do not simply stop the moment a pen runs out. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber decides whether it is right for you following a clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide is designed to stay active far longer than natural gut hormones, which break down within minutes. The SmPC on the electronic Medicines Compendium confirms a terminal half-life of approximately five days, which means that at the point your next weekly injection is due, a meaningful concentration of the medicine is still present. That overlap is deliberate: it smooths out the peaks and troughs that would otherwise make appetite suppression patchy.
The practical consequence is that if you miss a dose, you do not immediately feel as hungry as you did before starting treatment. Most people notice the effects of a missed injection only after ten days or so, once plasma levels have dropped substantially. This is one reason the question of how long tirzepatide takes to wear off matters for anyone considering a pause, a surgical procedure, or a switch to a different medicine.
Understanding the half-life also corrects a common misconception: some people expect to feel dramatically different the day after their injection versus six days later. In practice the blood levels (and the appetite-suppressing effect) are relatively stable across the week, especially once you are on a steady maintenance dose. The variation is there, but it is smaller than most expect.
Tirzepatide slows gastric emptying and activates both GIP and GLP-1 receptors to reduce appetite. As plasma levels fall over the four-to-five weeks following your last injection, both of those effects gradually unwind. Hunger typically returns, meals feel satisfying for shorter periods, and the calorie deficit that drove weight loss narrows.
The clearest evidence for what follows comes from the SURMOUNT-4 trial, referenced in NICE's appraisal of tirzepatide (TA1026): participants who had lost weight during an initial treatment phase and were then switched to placebo regained a substantial portion of it over the following year. The medicine does not permanently reset physiology; the underlying biological drives toward weight regain re-emerge once treatment stops. This is consistent with how the NHS frames obesity — as a long-term condition, not one fixed by a course of tablets.
If you are thinking about cost alongside duration of treatment, our Mounjaro cost page sets out what private treatment typically involves. The question of how long you continue is a clinical one, reviewed at each prescription.
There is no sharp cliff. Because tirzepatide accumulates with weekly dosing over the first few weeks and has that five-day half-life, levels decline in a curve rather than a drop. By roughly ten days after your final injection you will have about a quarter of peak levels remaining; by three to four weeks that falls to trace amounts. Most people report noticing a meaningful return of appetite somewhere in the second or third week after stopping, and our page on how long it takes for Mounjaro to wear off goes into more detail on how this varies with body weight, kidney function and how long you had been on treatment.
The one area where timing matters most is surgery. NHS England guidance advises patients to tell their anaesthetist they are on tirzepatide before any procedure, because slower gastric emptying can affect the safety of general anaesthesia. Our page on how long to stop Mounjaro before surgery covers this in detail. For anyone wondering about the broader onset question, the mirror question (how long it takes for Mounjaro to start working) is covered separately.
Stopping should always be a decision made with your prescriber. The clearance timeline above is pharmacological fact; the right moment to stop, pause or continue is a clinical judgement that factors in your health, your goals and any other medicines you take. Our clinical team at nume reviews every prescription individually, including repeat orders and dose changes, there are no automated renewals.
If you are stopping Mounjaro intentionally (because of a planned surgery, a pregnancy attempt, or a clinical decision to try without it) the washout window of four to five weeks is worth planning around. Protein intake and regular meals help blunt the return of appetite; the NHS healthy weight guidance covers the dietary basics that support weight maintenance. Strength-based activity matters too, because muscle mass is one of the best physiological buffers against weight regain.
For people considering whether to start or continue treatment, the Mounjaro treatment overview sets out what the licensed dose schedule involves and what to expect at each stage. If you are already on treatment and want to understand the trajectory better, our prescribers are available seven days a week through priority aftercare, no appointment needed, no premium rate number.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.